Survival benefit of multimodal local therapy for repeat recurrence of thoracic esophageal squamous cell carcinoma after esophagectomy

被引:4
|
作者
Ninomiya, Itasu [1 ]
Okamoto, Koichi [1 ]
Fushida, Sachio [1 ]
Kinoshita, Jun [1 ]
Takamura, Hiroyuki [1 ]
Tajima, Hidehiro [1 ]
Makino, Isamu [1 ]
Miyashita, Tomoharu [1 ]
Ohta, Tetsuo [1 ]
机构
[1] Kanazawa Univ, Dept Gastroenterol Surg, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan
关键词
Esophageal neoplasm; Recurrence; Surgery; Intensity-modulated radiotherapy; LYMPH-NODE DISSECTION; INTENSITY-MODULATED RADIOTHERAPY; EXTENDED RADICAL ESOPHAGECTOMY; THORACOSCOPIC ESOPHAGECTOMY; CURATIVE RESECTION; RADIATION-THERAPY; CANCER; PATTERN;
D O I
10.1007/s10388-018-0638-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundThis study was performed to clarify the optimal therapeutic strategy for recurrent disease after esophagectomy.MethodsWe investigated the prognosis of 37 patients who developed recurrence among 128 patients who underwent curative thoracoscopic esophagectomy (TE) at Kanazawa University Hospital. The prognostic factors after recurrence were examined by univariate and multivariate analyses.ResultsOf these 37 recurrences, 29 patients underwent local therapy (surgery, 10 patients; surgery followed by radiation, 2 patients; radiation, 17 patients). Radiation includes intensity-modulated radiation therapy, chemoradiation, and simple radiation therapy. Seventeen patients (58.6%) were considered to have undergone successful therapy by disappearance or diminishment of the targeted region without regrowth. Eleven of 17 patients (64.7%) showed repeat recurrence at another site. Multiple local therapy was performed for repeat recurrence or uncontrollable first therapy. Finally, 57 local therapies were performed. Using multimodal local therapy, 37 (64.9%) of 57 recurrences were successfully managed. The 12 patients treated by surgery as the initial therapy showed the most favorable survival. Seventeen patients who underwent successful initial therapy showed better survival than others. Multiple or miscellaneous organ metastasis, abdominal lymphatic recurrence and best supportive care at recurrence were statistically significant negative variables for survival after recurrence. Performance of surgery and successful therapy as the initial recurrence were statistically significant positive variables for survival after recurrence. Multivariate analysis showed that successful therapy at the initial recurrence was the only independent variable for survival after recurrence.ConclusionsMultimodal local therapy for repeat recurrence after TE contributes to the improvement of survival after recurrence.
引用
收藏
页码:107 / 113
页数:7
相关论文
共 50 条
  • [41] Pattern of recurrence after extended esophagectomy for squamous cell carcinoma of the esophagus
    Kyriazanos, ID
    Tachibana, M
    Shibakita, M
    Yoshimura, H
    Kinugasa, S
    Dhar, DK
    Nakamoto, T
    Fujii, T
    Nagasue, N
    HEPATO-GASTROENTEROLOGY, 2003, 50 (49) : 115 - 120
  • [42] The application of neoadjuvant therapy in thoracic esophageal squamous cell carcinoma
    Hao, Yanmei
    Zhu, Chaomang
    Tao, Suyu
    Li, Duojie
    Wei, Nannan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (05): : 6275 - 6282
  • [43] Recurrence Pattern of Squamous Cell Carcinoma in the Middle Thoracic Esophagus after Modified Ivor-Lewis Esophagectomy
    Gang Chen
    Zhou Wang
    Xiang-yan Liu
    Fan-ying Liu
    World Journal of Surgery, 2007, 31 : 1108 - 1115
  • [44] Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified ivor-lewis esophagectomy
    Chen, Gang
    Wang, Zhou
    Liu, Xiang-yan
    Liu, Fan-ying
    WORLD JOURNAL OF SURGERY, 2007, 31 (05) : 1107 - 1114
  • [45] Adjuvant Chemotherapy After Esophagectomy: Is There a Role in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma?
    Lyu, Xiao
    Huang, Jing
    Mao, Yousheng
    Liu, Yutao
    Feng, Qinfu
    Shao, Kang
    Gao, Shugeng
    Jiang, Yong
    Wang, Jinwan
    He, Jie
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 110 (07) : 864 - 868
  • [46] High Body Mass Index Worsens Survival in Patients with Esophageal Squamous Cell Carcinoma after Esophagectomy
    Duan, Xiao-Feng
    Tang, Peng
    Shang, Xiao-Bin
    Jiang, Hong-Jing
    Zhao, Qiang
    Yu, Zhen-Tao
    DIGESTIVE SURGERY, 2017, 34 (04) : 319 - 327
  • [47] Long-Term Survival After Esophagectomy for Early Esophageal Squamous Cell Carcinoma in Linxian, China
    Song, Philip I.
    Liang, Hao
    Fan, Jin-Hu
    Wei, Wen-Qiang
    Wang, Guo-Qing
    Qiao, You-Lin
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (02) : 176 - 180
  • [48] Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma
    Hamai, Yoichi
    Emi, Manabu
    Ibuki, Yuta
    Murakami, Yuji
    Nishibuchi, Ikuno
    Nagata, Yasushi
    Furukawa, Takaoki
    Kurokawa, Tomoaki
    Ohsawa, Manato
    Okada, Morihito
    ANTICANCER RESEARCH, 2019, 39 (03) : 1433 - 1440
  • [49] Clinical impact of remnant lymphatic invasion on the recurrence of esophageal squamous cell carcinoma after esophagectomy with neoadjuvant chemotherapy
    Okuda, Sho
    Ohuchida, Kenoki
    Shindo, Koji
    Moriyama, Taiki
    Kawata, Jun
    Tamura, Koji
    Sada, Masafumi
    Nagayoshi, Kinuko
    Mizuuchi, Yusuke
    Ikenaga, Naoki
    Nakata, Kohei
    Oda, Yoshinao
    Nakamura, Masafumi
    ONCOLOGY LETTERS, 2022, 24 (04)
  • [50] Risk factors for tumor recurrence in patients with pT3N0M0 thoracic esophageal squamous cell carcinoma after esophagectomy
    Feng, Wei
    Qi, Zhan
    Qiu, Rong
    Li, Zhen-Sheng
    Dong, Shi-Lei
    Li, Yue-Kao
    Hu, Yuan-Ping
    He, Ming
    Wang, Yu-Xiang
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (12)